HomeCompareCLNXF vs JNJ

CLNXF vs JNJ: Dividend Comparison 2026

CLNXF yields 1.47% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.3K in total portfolio value· pulled ahead in Year 5
10 years
CLNXF
CLNXF
● Live price
1.47%
Share price
$30.64
Annual div
$0.45
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.15
Full CLNXF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CLNXF vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLNXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLNXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLNXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLNXF
Annual income on $10K today (after 15% tax)
$125.23/yr
After 10yr DRIP, annual income (after tax)
$0.13/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,985.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLNXF + JNJ for your $10,000?

CLNXF: 50%JNJ: 50%
100% JNJ50/50100% CLNXF
Portfolio after 10yr
$25.1K
Annual income
$2,344.77/yr
Blended yield
9.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLNXF
No analyst data
Altman Z
0.4
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLNXF buys
0
JNJ buys
0
No recent congressional trades found for CLNXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLNXFJNJ
Forward yield1.47%2.13%
Annual dividend / share$0.45$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$19.9K$30.3K
Annual income after 10y$0.15$4,689.40
Total dividends collected$148.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLNXF vs JNJ ($10,000, DRIP)

YearCLNXF PortfolioCLNXF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,774$73.67$10,592$272.30+$182.00CLNXF
2$11,565$37.09$11,289$357.73+$276.00CLNXF
3$12,393$18.60$12,123$472.89+$270.00CLNXF
4$13,270$9.32$13,141$629.86+$129.00CLNXF
5← crossover$14,203$4.66$14,408$846.81$205.00JNJ
6$15,200$2.33$16,021$1,151.60$821.00JNJ
7$16,265$1.17$18,122$1,588.22$1.9KJNJ
8$17,404$0.58$20,930$2,228.20$3.5KJNJ
9$18,623$0.29$24,792$3,191.91$6.2KJNJ
10$19,927$0.15$30,274$4,689.40$10.3KJNJ

CLNXF vs JNJ: Complete Analysis 2026

CLNXFStock

Cellnex Telecom, S.A. operates infrastructure for wireless telecommunication in Austria, Denmark, Spain, France, Ireland, Italy, the Netherlands, Poland, Portugal, the United Kingdom, Sweden, and Switzerland. It operates through three segments: Telecom Infrastructure Services, Broadcasting Networks, and Network Services and Others. The company offers co-location services in its infrastructure for mobile operators to install telecommunications and wireless broadcasting equipment; distributed antenna system and small cells, a network of spatially separated antenna nodes connected to a common source through transport medium that provides wireless services. It also provides broadcasting network services, including digital terrestrial television (DTT), hybrid DTT, satellite DTT services, and premium DTT services; FM and digital radio services; and internet media services, such as online multiscreen video solutions, online business support solutions, and content distribution services. In addition, it offers data transportation services comprising satellite transportation, digital terrestrial circuits, Amazon direct connect, and internet throughput services; security and control services, which include security and emergency networks, terminals, forest fire early warning systems, and control centers; and smart communication networks, including wireless broadband, irrigation management services in rural settings, and Internet of Things services. Further, it offers smart services for city management; engineering/consulting, and operation and maintenance services; and constructs and operates optic fiber telecommunications. The company serves mobile network operators, broadcasters, and administrations. The company was formerly known as Abertis Telecom Terrestre, S.A.U. and changed its name to Cellnex Telecom, S.A. in April 2015. Cellnex Telecom, S.A. was incorporated in 2008 and is headquartered in Madrid, Spain.

Full CLNXF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CLNXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLNXF vs SCHDCLNXF vs JEPICLNXF vs OCLNXF vs KOCLNXF vs MAINCLNXF vs ABBVCLNXF vs MRKCLNXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.